Narsoplimab: First Approval

Drugs 2026

View at publisher
Authors: Matt Shirley
DOI: 10.1007/s40265-026-02328-8
Cited by: 1
References: 10

Fields of Study & Subjects

HER2/EGFR in Cancer Research Peptidase Inhibition and Analysis Melanoma and MAPK Pathways

Publication details

Journal / source
Drugs
Publisher
Springer Science and Business Media LLC
Volume
86
Issue
7
Pages
1165–1170
Publication date
18 May 2026
Language
EN